Are paroxetine, fluoxetine, and sertraline equally effective for depression?
Straton, J.B.; Cronholm, P.
Journal of Family Practice 51(3): 285
2002
ISSN/ISBN: 0094-3509 PMID: 11978244 Document Number: 551140
Document emailed within 1 workday
Related Documents
Polsky, D.; Onesirosan, P.; Bauer, M.S.; Glick, H.A. 2002: Duration of therapy and health care costs of fluoxetine, paroxetine, and sertraline in 6 health plans Journal of Clinical Psychiatry 63(2): 156-164Bennie, E.H.; Mullin, J.M.; Martindale, J.J. 1995: A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression Journal of Clinical Psychiatry 56(6): 229-237
Dominguez, R.A.; Kumar, A.M.; Cua, W. 1996: Lack of change in fluoxetine and norfluoxetine kinetics when switching from fluoxetine to paroxetine Journal of Clinical Psychopharmacology 16(4): 320-323
Hritzak, K.; Culhane, N.S. 2004: Sertraline effective for children and adolescents with major depression Journal of Family Practice 53(1): 11-12
Alderman, J.; Preskorn, S.H.; Greenblatt, D.J.; Harrison, W.; Penenberg, D.; Allison, J.; Chung, M. 1997: Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers Journal of Clinical Psychopharmacology 17(4): 284-291
Kreider, M.S.; Bushnell, W.D.; Oakes, R.; Wheadon, D.E. 1995: A double-blind, randomized study to provide safety information on switching fluoxetine-treated patients to paroxetine without an intervening washout period Journal of Clinical Psychiatry 56(4): 142-145
Thase, M.E.; Blomgren, S.L.; Birkett, M.A.; Apter, J.T.; Tepner, R.G. 1997: Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline Journal of Clinical Psychiatry 58(1): 16-21
Remez, L. 2003: Three Differing Emergency Contraceptive Regimens Are Equally Effective International Family Planning Perspectives 29(2): 98-99
Sherman, T.L.; McDougle, C.J.; Price, L.H. 1993: Paroxetine: a new serotonin reuptake inhibitor for the treatment of depression Connecticut Medicine 57(9): 587-592
Newport, D.J.; Stowe, Z.N. 2003: Clinical management of perinatal depression: focus on paroxetine Psychopharmacology Bulletin 37(Suppl 1): 148-166
van Maarseveen, E.M.; Man, W.Hong.; Touw, D.J.; Bouma, A.W.; van Zanten, A.R.H. 2011: Continuous and intermittent infusion of vancomycin equally effective: review of the literature Nederlands Tijdschrift Voor Geneeskunde 155(42): A2667
Benazzi, F. 1998: Sertraline discontinuation syndrome presenting with severe depression and compulsions Biological Psychiatry 43(12): 929-930
Chander, W.P.; Singh, N.; Mukhiya, G.K. 2011: Serotonin syndrome in maintenance haemodialysis patients following sertraline treatment for depression Journal of the Indian Medical Association 109(1): 36-37
Rickels, K.; Amsterdam, J.; Clary, C.; Fox, I.; Schweizer, E.; Weise, C. 1992: The efficacy and safety of paroxetine compared with placebo in outpatients with major depression Journal of Clinical Psychiatry 53(Suppl): 30-32
Wacharasint, P.; Lertamornpong, A.; Wattanathum, A.; Wongsa, A. 2012: Predicting fluid responsiveness in septic shock patients by using 3 dynamic indices: is it all equally effective? Journal of the Medical Association of Thailand 95(Suppl 5): S149-S156
Xia, X-tao.; Sun, N.; Liu, C-chun.; Qin, X-mei.; Tian, J-sheng. 2016: Discovering potential biomarkers of depression and drug intervention of paroxetine based on (1)H NMR metabolomics Yao Xue Xue Bao 51(4): 595-599
2004: Olanzapine/Fluoxetine (Symbyax) for bipolar depression Medical Letter on Drugs and Therapeutics 46(1178): 23-24
Montgomery, S.A.; Dufour, H.; Brion, S.; Gailledreau, J.; Laqueille, X.; Ferrey, G.; Moron, P.; Parant-Lucena, N.; Singer, L.; Danion, J.M. 1988: The prophylactic efficacy of fluoxetine in unipolar depression British Journal of Psychiatry. Suppl 3: 69-76
Smajkić, A.; Weine, S.; Durić-Bijedić, Z.; Boskailo, E.; Lewis, J.; Pavković, I. 2001: Sertralilne, paroxetine and venlafaxine in refugee post traumatic stress disorder with depression symptoms Medicinski Arhiv 55(1 Suppl 1): 35-38
Nemeroff, C.B. 1993: Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression Journal of Clinical Psychopharmacology 13(6 Suppl 2): 10s-17s